A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2011
06/01/2011	CN101756761B Heating patch with coupling agent and preparation process thereof
06/01/2011	CN101732667B Traditional Chinese medicine for eliminating blood stasis and smoothing collaterals
06/01/2011	CN101664527B Chinese traditional medicine for curing sciatica
06/01/2011	CN101607016B External medicine for treating swelling from blood stases
06/01/2011	CN101454003B Oral composition comprising 3-[5-[4-(cyclopentyloxy) -2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6- yl)methoxy]phenyl]propionic acid or salt thereof
06/01/2011	CN101347595B Chinese medicine for treating rheumatic heart of children
06/01/2011	CN101342244B Traditional Chinese medicine bone setting powder for treating rheumatism bone disease based on hot-salt method
06/01/2011	CN101254255B Traditional Chinese medicine preparation for curing cold
06/01/2011	CN101204429B Extractive of total peony ladves flavone-glycoides, preparation method and uses thereof
06/01/2011	CN101194936B Application of giant knotweed rhizome toluylene total glycosides in preparing medicament for treating rheumatic disease
06/01/2011	CN101099860B Use of erythropoietin
05/2011
05/31/2011	US7951972 Human adam-10 inhibitors
05/31/2011	US7951820 Triazole compounds useful as protein kinase inhibitors
05/31/2011	US7951812 For abnormal cell proliferation, inflammatory diseases, asthma, and arthritis; (S)-N-{4-[2-(2,4-diamino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-4-methylene-L-glutamic acid disodium salt (CHL1007)
05/31/2011	US7951811 Pyrrolo[2,3-D]pyrimidine derivatives substituted with a cyclic amino group
05/31/2011	US7951810 Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of E1 activating enzymes
05/31/2011	US7951801 Beta-carbolines useful for treating inflammatory disease
05/31/2011	US7951793 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
05/31/2011	US7951772 Tumor-activated prodrug compounds and treatment
05/31/2011	US7951371 Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling
05/31/2011	CA2533515C Heteroaryl-tetrahydropyridyl compounds useful for treating or preventing pain
05/31/2011	CA2475764C New inhibitors of histone deacetylase
05/31/2011	CA2466135C Use of propionyl l-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie's disease
05/31/2011	CA2465750C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]-indole-1-carboxamide derivatives, their preparation and therapeutic use
05/31/2011	CA2455635C Use of thiazole derivatives for preparing a medicine for protecting mitochondria
05/31/2011	CA2400929C Antagonistic selective binding agents of osteoprotegerin binding protein
05/31/2011	CA2398929C Neuroprotective, antithrombotic and anti-flammatory uses of activated protein c (apc)
05/26/2011	WO2011062955A2 Compounds for modulating tlr2
05/26/2011	WO2011062253A1 Novel fused pyrimidine derivative
05/26/2011	WO2011061743A1 Metadoxine and derivatives thereof for use in the treatment of inflammation and immune-related disorders
05/26/2011	WO2011061340A1 Inhibitors of the pp1/gadd34 complex for the treatment of a condition requiring an immunosuppressive activity
05/26/2011	WO2011061330A2 Use of physiological cooling active ingredients, and agents containing such active ingredients
05/26/2011	WO2011060962A1 Salts of duloxetine and nsaids for the treatment of pain
05/26/2011	WO2011041609A3 Topical formulations
05/26/2011	US20110126299 Triple transgenic mouse model of autoimmune disease and nf-kappa b in vivo imaging
05/26/2011	US20110124739 Use of Sphingosine-1-phosphate (S1P) Receptor Agonists for the Treatment of Brain Degenerative Diseases
05/26/2011	US20110124735 Carbonylamino derivatives useful for the treatment of certain inflammatory disorders
05/26/2011	US20110124730 Oral pharmaceutical suspension comprising paracetamol and ibuprofen
05/26/2011	US20110124727 Oxybuprocaine-Containing Analgesic/Antipruritic External Preparation
05/26/2011	US20110124721 Methods of treating traumatic brain injury by administering baicalein preparation
05/26/2011	US20110124711 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE
05/26/2011	US20110124702 Nanosuspension of a Poorly Soluble Drug via Microfluidization Process
05/26/2011	US20110124695 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
05/26/2011	US20110124693 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory diseases
05/26/2011	US20110124684 Aminopyrazole triazolothiadiazole inhibitors of c-met protien kinase
05/26/2011	US20110124680 Novel anthranilamide pyridinureas as vascular endothelial growth factor (vegf) receptor kinase inhibitors
05/26/2011	US20110124673 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
05/26/2011	US20110124672 Thienyl Compounds
05/26/2011	US20110124671 Spiroindenes and spiroindanes as modulators of chemokine receptors
05/26/2011	US20110124668 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group
05/26/2011	US20110124666 3,4-dihydropyrimidine trpa1 antagonists
05/26/2011	US20110124657 Method for screening of 5ht7 receptor ligands based on a new pharmacophore model and a descriptor's profile filter
05/26/2011	US20110124650 Stable crystalline salts of antifolate compounds
05/26/2011	US20110124646 Novel cyclic compound having pyrimidinylalkylthio group
05/26/2011	US20110124645 Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
05/26/2011	US20110124642 Potassium channel modulators
05/26/2011	US20110124641 Benzothiazole kinase inhibitors and methods of use
05/26/2011	US20110124640 Fused heterocyclic compounds useful as kinase modulators
05/26/2011	US20110124625 Modulators of Cellular Adhesion
05/26/2011	US20110124624 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory diseases
05/26/2011	US20110124622 Isoindolones derivatives as mek kinase inhibitors and methods of use
05/26/2011	US20110124620 Sphingosine 1 phosphate receptor moduators and their use to treat muscle inflammation
05/26/2011	US20110124619 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
05/26/2011	US20110124614 Methods And Compositions For The Treatment of Autoimmune Disorders
05/26/2011	US20110124601 Aminophosphinic derivatives that can be used in the treatment of pain
05/26/2011	US20110124599 2,4-Pyrimidinediamine Compounds and Prodrugs and Their Uses
05/26/2011	US20110124596 Composition for treating inflammatory diseases
05/26/2011	US20110124589 Inhaled fosfomycin/tobramycin for the treatment of chronic obstructive pulmonary disease
05/26/2011	US20110124585 Dimeric Small Molecule Potentiators of Apoptosis
05/26/2011	US20110124577 Preparation for oral administration comprises quercetin glycoside and a water-based solvent extract of cartilage containing chondroitin sulfate
05/26/2011	US20110124562 Apoaequorin-containing compositions and methods of using same
05/26/2011	US20110124560 Foxp3 oligomerization and intermolecular interactions
05/26/2011	US20110124550 Thymosin beta 4 promotes wound repair
05/26/2011	US20110123702 Room temperature-curable polymers
05/26/2011	US20110123651 Dietary supplement drink for delivery of resveratrol and other polyphenols
05/26/2011	US20110123648 Use of coconut water extract or coconut shell extract for treating immunological diseases and/or disorders
05/26/2011	US20110123630 Topical treatment of peripheral neuropathy
05/26/2011	US20110123623 Rhamnolipid mechanism
05/26/2011	US20110123619 Buccal delivery system
05/26/2011	US20110123608 Pharmaceutical formulation
05/26/2011	US20110123554 Uses of immunoconjugates targeting cd138
05/26/2011	US20110123551 Hvem/btla, hvem/cd 160 and hvem/gd cis complexes and methods of use
05/26/2011	US20110123543 TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease
05/26/2011	US20110123538 Composition comprising expression or activity inhibitors of ninjurin 1 for the prevention and treatment of inflammatory disease
05/26/2011	US20110123531 Combination therapy
05/26/2011	US20110123528 Humanized anti-factor d antibodies and uses thereof
05/26/2011	US20110123525 Anti-angiogenic therapy
05/26/2011	US20110123517 Dissolvable pharmaceutical implant
05/26/2011	US20110123506 Dietary health food composition, package and method of use
05/26/2011	US20110123484 Methods and compositions for treating fus1 related disorders
05/26/2011	US20110123460 Pharmaceutical formulation for treating the upper digestive tract
05/26/2011	US20110123436 Dock-and-Lock (DNL) Complexes for Delivery of Interference RNA
05/26/2011	US20110123435 Compounds for inhibiting ksp kinesin activity
05/26/2011	DE102009054302A1 Chinazolinderivate Quinazoline derivatives
05/26/2011	CA2781194A1 Reducing inflammation using cell therapy
05/26/2011	CA2780912A1 Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders
05/25/2011	EP2325317A1 Receptor nucleic acids and polypeptides
05/25/2011	EP2325300A1 Desaturase genes and uses thereof
05/25/2011	EP2325205A2 Crystals of whole antibodies and fragments thereof and methods for making and using them
05/25/2011	EP2325193A2 Methods and compositions for therapeutic use of RNA interference

1 ... 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 ... 1272